Prostatectomy

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments with related expertise

Areas that research this procedure

Research

Doctors and scientists in urology research at Mayo Clinic are studying new treatment options for prostate cancer and other urologic conditions. Researchers are actively involved in studying long-term outcomes after radical prostatectomy.

For decades, Mayo Clinic has been compiling a database from records of people who have had surgery for prostate cancer. Mayo researchers use this information to monitor outcomes, search for trends and ensure overall quality of care.

Prostate cancer research is conducted in coordination with the Mayo Clinic Comprehensive Cancer Center. The Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

The Department of Urology at Mayo Clinic is engaged in continuous research to advance new treatment options for prostate cancer and other urologic conditions. Recent studies include evaluating quality of life and operative outcomes after robot-assisted prostatectomy. This type of research allows Mayo Clinic surgeons to provide the highest level of care for people who have this procedure. Additional research is being done on the biology of prostate cancer.

Publications

See a list of publications about prostatectomy by Mayo Clinic authors on PubMed, a service of the National Library of Medicine.

By Mayo Clinic Staff

Prostatectomy care at Mayo Clinic

Request an appointment
AboutCare at Mayo Clinic
Sept. 07, 2024
Print
  1. Lomas DJ, et al., eds. Mayo Clinic on Prostate Health. 3rd ed. Mayo Clinic Press; 2022.
  2. McVary KT. Surgical treatment of benign prostatic hyperplasia (BPH). https://www.uptodate.com/contents/search. Accessed March 22, 2024.
  3. Health Education & Content Services. Treating benign prostatic hyperplasia (BPH). Mayo Clinic; 2021.
  4. Surgery for prostate cancer. Prostate cancer foundation. https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/surgery-prostate-cancer/. Accessed March 22, 2024.
  5. Partin AW, et al., eds. Simple prostatectomy: Open and robotic-assisted laparoscopic approaches. In: Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed April 1, 2020.
  6. Surgery for prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/treating/surgery.html. Accessed March 22, 2024.
  7. Moreira DM, et al. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU International. 2017; doi:10.1111/bju.13266.
  8. Motterle G, et al. The role of radical prostatectomy and lymph node dissection in clinically node positive patients. Frontiers in Oncology. 2019; doi:10.3389/fonc.2019.01395.
  9. Ami T. Allscripts EPSi. Mayo Clinic. March 29, 2024.
  10. Costello AJ. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nature Reviews|Urology. 2020; doi:10.1038/s41585-020-0287-y.
  11. Agarwal DK, et al. Initial experience with da Vinci single-port robot-assisted radical prostatectomies. European Urology. 2020; doi:10.1016/j.eururo.2019.04.001.
  12. Ashfaq A, et al. Incidence and outcomes of ventral hernia repair after robotic retropubic prostatectomy: A retrospective cohort of 570 consecutive cases. International Journal of Surgery. 2017; doi:10.1016/j.ijsu.2016.12.034.
  13. Moris L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Frontiers in Surgery. 2016; doi:10.3389/fsurg.2016.00065.
  14. Kaushik D, et al. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. International Brazilian Journal of Urology. 2016; doi:10.1590/S1677-5538.IBJU.2016.0290.
  15. Alshalalfa M, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients. Oncotarget. 2017; doi:10.18632/oncotarget.15133.
  16. Preparing for surgery: Checklist. American Society of Anesthesiologists. https://www.asahq.org/madeforthismoment/preparing-for-surgery/prep/preparing-for-surgery-checklist/. Accessed March 26, 2024.
  17. Dess RT, et al. Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer. JAMA Oncology. 2020; doi:10.1001/jamaoncol.2020.0109.
  18. Richie JP. Radical prostatectomy for localized prostate cancer. https://www.uptodate.com/contents/search. Accessed March 25, 2024.

Related

Products & Services

Prostatectomy